Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02831101Completed
Randomised, double-blind trial of sufentanil. Primary endpoints: Bispectral Index at baseline and Bispectral Index and sufentanil. Started Feb 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02831101.